Where does Patrick Enright work?

Patrick Enright is Managing Director at Longitude Capital and Board director at Zenas Biopharma and Board director at Endeavor Biomedicines and Board director at Aptinyx.

What does Patrick Enright invest in?

Patrick Enright invests in Biotech, Healthtech, Medical Devices.

Where did Patrick Enright go to school?

Patrick Enright studied at University of Pennsylvania (MBA); Stanford University (BS, Biology).

Patrick Enright

Investor

Managing Director at Longitude Capital · Board director at Zenas Biopharma · Board director at Endeavor Biomedicines · Board director at Aptinyx

Menlo Park

About

Managing Director and Founder who co-led the life sciences practice at Pequot Ventures and has extensive biotech operating experience. He holds an MBA from Wharton and a BS from Stanford.

Contact· self-published, not guessed

p•••@longitudecapital.comreveal

Likely email· guessed from name + firm domain, not firm-published

p•••@longitudecapital.comreveal100% confident

Invests in

BiotechHealthtechMedical Devices

Board director at Zenas Biopharma

Intro paths

→

In turn, Patrick can intro founders to Zenas Biopharma's investors below.

Zenas Biopharma's investors · 8

Agent CapitalWaltham · since 2022 Delos CapitalCambridge Longitude CapitalMenlo Park · $10M – $30M checks New Enterprise Associates (NEA)Menlo Park · $200K – $40M checks Norwest Venture PartnersMenlo Park · $10M – $30M checks Quan CapitalShanghai SR One Capital ManagementRedwood City · since 2024 Vivo CapitalPalo Alto · $10M – $50M checks

Co-founders at Zenas Biopharma

LEON O. MOULDER, JR.Director

Lonnie MoulderFounder, CEO & Chairman

Board director at Endeavor Biomedicines

Intro paths

→

In turn, Patrick can intro founders to Endeavor Biomedicines's investors below.

Endeavor Biomedicines's investors · 2

Fidelity InvestmentsBoston Longitude CapitalMenlo Park · $10M – $30M checks

Co-founders at Endeavor Biomedicines

John HoodDirector, Executive Officer

Board director at Aptinyx

Intro paths

→

In turn, Patrick can intro founders to Aptinyx's investors below.

Aptinyx's investors · 6

Bain Capital Life SciencesBoston · since 2017 Frazier Life SciencesPalo Alto · since 2016 Latterell Venture PartnersSan Ramon · $50K – $10M checks Longitude CapitalMenlo Park · $10M – $30M checks National Institutes of Health (NIH)since 2016 OUP (Osage University Partners)Bala Cynwyd · $1M – $20M checks

Co-founders at Aptinyx

Joseph R. MoskalChief Scientific Officer

Experience

VeradermicsBoard Membercurrent2024 — present
Zenas BioPharmaBoard Membercurrent2022 — presentBoston, Massachusetts, United States
Endeavor BiomedicinesBoard Membercurrent2022 — presentSan Diego, California, United States
Vera Therapeutics, Inc.Member Board of Directorscurrent2020 — present
Jazz PharmaceuticalsBoard Membercurrent2009 — present
Epirium, Inc.Board Membercurrent2019 — present
CuraSen Therapeutics, Inc.Board Membercurrent2018 — present
Orbus TherapeuticsBoard Membercurrent2015 — present
LEMO FoundationBoard Membercurrent2012 — present
Longitude CapitalManaging Directorcurrent2006 — present
MAP Pharma, Horizon, Sequenom, Codexis, Threshold, Esperion, Infacare, NVCAPrior Board appointments (since resigned)current2002 — present
Rivus PharmaceuticalsBoard Member2019 — 2024Charlottesville, Virginia, United States
Aptinyx Inc.Board Member2016 — 2022United States
Aimmune TherapeuticsBoard Member2013 — 2020
VaxcyteBoard Member2015 — 2020
Pequot CapitalManaging Director2002 — 2007

Colleagues at Longitude Capital

Advani

Senior Associate at Longitude Capital

Bakker

Managing Director & Founder at Longitude Capital

Bethany Chen

Senior Associate at Longitude Capital

Bikoff

Managing Director at Longitude Capital

Brian Liu

Managing Director at Longitude Capital

Cabreros

Director of Operations & Facilities at Longitude Capital

Callum Gallacher

Business Development Manager at Beringea

Carolyn Helms

Managing Director and CFO at Longitude Capital

Frequently asked questions

Who is Patrick Enright?: Managing Director and Founder who co-led the life sciences practice at Pequot Ventures and has extensive biotech operating experience. He holds an MBA from Wharton and a BS from Stanford.
Where does Patrick Enright work?: Patrick Enright is Managing Director at Longitude Capital and Board director at Zenas Biopharma and Board director at Endeavor Biomedicines and Board director at Aptinyx.
What does Patrick Enright invest in?: Patrick Enright invests in Biotech, Healthtech, Medical Devices.
Where did Patrick Enright go to school?: Patrick Enright studied at University of Pennsylvania (MBA); Stanford University (BS, Biology).